Future studies using Sox9-CreER–mediated Jag1 deletion/KrasG12D expression in conjunction with pancreatic duct ligation or p53 deletion may determine whether Jag1 plays a role in ductal-originated pancreatic cancer. The gene discussed is TP53; the disease is pancreatic neoplasm.